We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Providence published findings today demonstrating appreciable declines in unplanned hospitalizations along with an increase in hospital mortality for a broad mix of medical conditions during the COVID-19 pandemic.
Biological E has entered into an agreement with Canada-based Providence Therapeutics Holdings, to manufacture the latter’s mRNA (messenger Ribonucleic acid) vaccine PTX-COVID19-B in India.